vTv Therapeutics (VTVT) Misses Q1 EPS by 117c

vTv Therapeutics (NASDAQ: VTVT) reported Q1 EPS of ($1.17). Revenue for the quarter came in at $1 million.

For earnings history and earnings-related data on vTv Therapeutics (VTVT) click here.

You May Also Be Interested In

• BofA sees Micron EPS topping $230 by FY30, calls peak fears overblown
• UBS: 'We Believe Dollar Tree (DLTR) is Turning From a Transformation to a Growth Story'
• BitFuFu Inc. (FUFU) Misses Q2 EPS by 13c